eMedevents
  • 142,958+ Medical Conferences
  • 279 Specialties
  • 10,771 Organizers
  • 153,905 Speakers
  • 156 Countries
  • 4,640 Cities
47,653+
CME Conference Registrations Sold
Home  >  Speakers  >  Avi Kulakarni
Avi Kulakarni

Avi Kulakarni

    PhD
Senior Vice-President, Director | Durham, North Carolina    United States of America
Biotechnology, Pharmacy And Medicine,...More
Biotechnology, Pharmacy,...More
Spoken at 1 event

Biography :

Dr. Kulkarni is the San Francisco based west region leader of QuintilesIMS Consulting Services. He has extensive experience in drug and diagnostics discovery and development, portfolio management, mergers and acquisitions, and commercialization processes. His clients include leading global biopharmaceutical companies. He is also Director of the QuintilesIMS Stem Cell Center in San Diego.

Prior to Quintiles, Avi was a Partner at Booz & Co., where he was the leader of the life sciences R&D business. He has been at the forefront of the transformation of the world’s leading Rx and Dx companies as they develop precision or personalized medicine capabilities and diversify into new businesses and markets.

Avi has deep roots in the biotechnology start-up community. He was a member of Sand Hill Angels till 2011. He has raised over $100MM for his start-up companies. He was CEO of Lumen Therapeutics (CV drugs), COO of Aviir (diagnostic tests for cardiovascular disease and insulin resistance) and CFO and head of Business Development of CareDx (XDx - AlloMap Cardiac gene expression testing).

**********************
**********
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Biotechnology, Pharmacy and Medicine, Nuclear Pharmacy

Interested Topics

Biotechnology, Pharmacy, Medicine, Strategy, Life Sciences, Bussiness Development, Commercialization

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message